You are here
Management Team
Ed Dineen
Ed Dineen is Chief Executive Officer of LS9 and a member of the LS9 Board of Directors. Most recently, he was Chief Operating Officer of LyondellBasell Industries, one of the world's largest polymers, petrochemical and fuels companies, where he was responsible for manufacturing, environmental, health and safety, business management and sales, research and development, supply and procurement and business finance.
read more
He previously was appointed President of the chemicals division and was responsible for the global chemicals operations, sales and business management. Prior to the December 2007 merger of Basell and Lyondell Chemical Company, he was Senior Vice President, Chemicals and Polymers for Lyondell, and before that, Senior Vice President, Urethanes and Performance Chemicals. During his time at LyondellBasell Industries and its predecessor companies, Mr. Dineen was directly involved in growing many of the fuels and chemicals businesses into global market leading positions.
A native of New York City, Mr. Dineen received his bachelor's and master's degrees in chemical engineering from the Cooper Union and Princeton University, respectively. He also holds a Master of Science in management from Drexel University. Mr. Dineen is also a member of the board of directors of Spartech, a U.S.-based plastics company with headquarters in St. Louis, Missouri.
Stephen del Cardayre
Stephen del Cardayre has broad responsibility for research and development, external collaborations, and day-to-day operations at LS9. Prior to joining LS9, Dr. del Cardayre spent 9 years at Codexis and Maxygen, where he was directly involved in the development, application, and commercialization of technologies for the engineering of biocatalytic processes for the pharmaceutical and chemical industry. Dr. del Cardayre has published extensively on the application of evolutionary engineering of biological systems, focusing primarily on the engineering of whole cell biocatalysts.
read more
By training, Dr. del Cardayre is a biochemist, receiving an undergraduate degree in Biochemistry from the University of California - Berkeley, a Ph.D. in Biochemistry from the University of Wisconsin-Madison, and Post doctoral training in Microbial Biotechnology at the University of British Columbia.
Wei Huang
Wei Huang has responsibility for process development, engineering, and scale up at LS9. Ms. Huang brings over 17 years of industrial bioprocess experience, including process scale up, facility and equipment design, process simulation, construction support, facility start-up, operation support, as well as process development and research.
read more
Prior to joining LS9, Ms. Huang was Director of Process Engineering at Fluor Corporation, one of the world's largest, publicly owned engineering companies. During her tenure there, Ms. Huang successfully led various engineering projects for the biotechnology industry worldwide. Prior to joining Fluor, she worked at Bechtel, North American Vaccine (now part of Baxter) and New Brunswick Scientific Inc, where she was directly involved in the process development, scale up and product commercialization for both biopharmaceuticals and industrial fermentation products. Active in a variety of professional organizations such as SIM, AIChE and ISPE, Ms. Huang serves as a committee member of ASME BPE. She is a well published author, a frequent speaker at various biotechnology events and a recipient of the ISPE Best Article of the Year award.
Ms. Huang received her M.S. in Chemical Engineering from the University of Maryland specializing in biochemical engineering.
Gregory (Greg) Rood
Greg comes to LS9 from Martek Biosciences/ DSM where he was the Senior VP of Operations responsible for the Kingstree, SC and Winchester, KY production and development sites.
read more
Prior to Martek Greg worked for Danisco Genencor where he spent 9 years as Vice President and General Manager for their Bio-products, Ltd. division, specifically overseeing all manufacturing and business operations in their China and India plants. Greg joined Genencor when it was still part of Eastman Kodak and remained an employee of the organization over 30+ years. He performed several significant roles for Genencor as Operations Manager, Plant Manager and Director of Contract Manufacturing.
Over the course of his tenure at Danisco Genencor, in addition to his international exposure, Greg accumulated extensive experience managing microbial fermentation operations and producing food ingredients. Among his more notable accomplishments, Greg managed the successful construction and ramp up of a large scale enzyme production facility in China, where he represented a strong presence with his employees and also with the leaders of Danisco.
Greg Rood is a native of Rochester NY where his family still resides. Greg majored in Chemistry and attended Monroe Community College and Rochester Institute of Technology as well as Notre Dame's Executive Management Certificate Program
Lucila de Avila
Lucila de Ávila is the Managing Director of LS9 Brazil, responsible for all the activities of LS9 in South America. Most recently, she was the Regional Director for the South American operations of Lyondellbasell Industries, one of the world's largest polymers, petrochemical and fuels companies, where she was responsible for all Business and Commercial activities in the continent for the Chemicals Division, and also Brazilian ethanol supply to the Fuels Division.
read more
Prior to this, she held several positions with the company and its predecessors, starting with commercial activities in Brazil and Mercosur. She started her career with The Dow Chemical Company, including a special assignment in the company’s New York Sales Office.
A native of São Paulo, Brazil, Lucila de Avila graduated in Chemical Engineering and Business Administration from Escola de Engenharia Mauá and Fundação Getulio Vargas, respectively.
Linda R. Judge
Linda R. Judge has broad responsibility for legal matters at LS9. Most recently, she was Vice President of Intellectual Property at AcelRx Pharmaceuticals, Inc., a pharmaceutical and medical device company, where she was responsible for intellectual property matters, drafting and revising agreements, conducting diligence and freedom-to-operate evaluations of relevant technologies, contributing to strategy regarding clinical and product development plans and oversight of general legal issues.
read more
Before joining AcelRx, Ms. Judge was a partner in the Intellectual Property law practice of DLA Piper US LLP where she worked on patent, licensing and litigation matters. Prior to that Ms. Judge was Director of Intellectual Property at Cell Genesys, Inc., a cancer therapeutics company. She also brings over 11 years of scientific experience in the laboratory setting as both a bench scientist and in a management capacity.
Ms. Judge has a J.D. from Santa Clara University, and an M.S. in Environmental Chemistry from U.C. Berkeley. She is admitted to practice law in California and is a registered Patent Attorney before the US Patent & Trademark Office.